A novel chemical created at the University of Illinois Chicago may offer an alternative to injections for the millions of people who suffer from an eye condition.
New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy, and perhaps even diabetes, according to new research conducted at the Indiana University School of Optometry.